Splenic marginal zone lymphoma – a clinicopathological study in a series of 16 patients

References

• Jaffe ES, Stein H, Vardiman JW. Tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer. 2001; 12-13.
   Google Scholar
• Thieblemont C. Clinical presentation and management of marginalzone lymphomas. Hematology 2005; 1: 307–313.
   Google Scholar
• Mollejo M, Camacho Fl, Algara P, Ruiz-Ballesteros E, García JF,Pins MA. Nodal and splenic marginal zone B-cell lymphomas. Hematol Oncol 2005; 23: 108–118.
   PubMed Web of Science ®Google Scholar
• Oscier D, Owen R, Johnson S. Splenic marginal zone lymphoma. Blood Rev 2005; 19: 39–51.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Felman P, Callet-Bauchu E et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95–103.
   PubMed Web of Science ®Google Scholar
• Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415–6420.
   PubMed Web of Science ®Google Scholar
• Chacon JI, Mollejo M, Muñoz E et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 2002; 100: 1648–1654.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Coiffier B. Management of marginal zone lymphomas. Curr Treat Options Oncol 2006; 7: 213–222.
   PubMedGoogle Scholar
• Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol 2003; 120: 759–764.
   PubMed Web of Science ®Google Scholar
• Camacho Fl, Mollejo M, Mateo MS et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 2001; 25: 1268–1276.
   PubMed Web of Science ®Google Scholar
• Sole F, Salido M, Espinet B et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 2001; 86: 71–77.
   PubMed Web of Science ®Google Scholar
• Arcaini L, Paulli M, Boveri E, Magrini U, Lazzarino M. Marginal zone-related neoplasms of splenic and nodal origin. Haematologica 2003; 88: 80–93.
   PubMed Web of Science ®Google Scholar
• Giannouli S, Paterakis G, Ziakas PD, Anagnostou D, Voulgarelis M. Splenic marginal zone lymphomas with peripheral CD5 expression. Haematologica 2004; 89: 113–114.
   PubMed Web of Science ®Google Scholar
• Pileri SA, Zinzani PL, Went P, Pileri Jr A, Bendandi M. Indolent lymphoma: the pathologist's viewpoint. Ann Oncol 2004; 15: 12–18.
   PubMed Web of Science ®Google Scholar
• Mateo MS, Mollejo M, Villuendas R et al. Molecular hetero-geneity of splenic marginal zone lymphoma: analysis of mutations in the 5' non-coding region of the bc1-6 gene. Leukemia 2001; 15: 628–634.
   PubMed Web of Science ®Google Scholar
• Bahler DW, Pindzola JA, Swerdlow SH. Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol 2002; 161: 81–88.
   PubMed Web of Science ®Google Scholar
• Audouin J, Le Tourneau A, Molina T et al. Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 2003; 122: 404–412.
   PubMed Web of Science ®Google Scholar
• Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood 2003; 101: 2464–2472.
   PubMed Web of Science ®Google Scholar
• Pich A, Fraire F, Fornari A et al. Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study. Eur J Haematol 2006; 76: 392–398.
   PubMed Web of Science ®Google Scholar
• Kent SA, Variakojis D, Peterson LC. Comparative study of marginal zone lymphoma involving bone marrow. Am J Clin Pathol 2002; 117: 698–708.
   PubMed Web of Science ®Google Scholar
• Schenka AA, Gascoyne RD, Duchayne E, Delsol G, Brousset P. Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma. Hum Pathol 2003; 34: 789–791.
   PubMed Web of Science ®Google Scholar
• Ya-In C, Brandwein J, Pantalony D, Chang H. Hairy cell leukaemia variant with features of intrasinusoidal bone marrow involvement. Arch Pathol Lab Med 2005; 129: 395–398.
   PubMed Web of Science ®Google Scholar
• Asatiani E, Cohen P, Ozdemirli M, Kessler CM, Mavromatis B, Chesson BD. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol 2004; 77: 144–146.
   PubMed Web of Science ®Google Scholar
• Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol 1999; 36: 148–154.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Felman P, Berger F et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 2002; 31: 41–47.
   Google Scholar
• Berger F, Traverse-Glehen A, Felman P et al. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma 2005; 5: 220–224.
   PubMedGoogle Scholar
• Ibbotson RE, Parker AE, Oscier DE. Splenic marginal zone lymphoma: 7q abnormalities. Methods Mol Med 2005; 115: 241–250.
   PubMedGoogle Scholar
• Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 2003; 36: 57–69.
   PubMed Web of Science ®Google Scholar
• Sole F, Woessner S, Florensa L et al. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol 1997; 98: 446449.
   Web of Science ®Google Scholar
• Callet-Bauchu E, Baseggio L, Felman P et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia 2005; 19: 1818–1823.
   PubMed Web of Science ®Google Scholar